Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: Discovery of novel leads for anticancer drug design

Planta Medica

Volumn 75, Issue 5, 2009, Pages 501-507

  Evidente, Antonio ^a   Kireev, Artem S ^b   Jenkins, Aaron R ^b   Romero, Anntherese E ^b   Steelant, Wim F A ^b   Van Slambrouck, Severine ^b   Kornienko, Alexander ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

Author keywords

Alkaloid; Amaryllidaceae; Apoptosis; Drug lead; Invasion

Indexed keywords

1 O ACETYLLYCORINE; 1,2 O,O DIACETYL ALPHA DIHYDROLYCORINE; 11 HYDROXYVITTATINE; 8 NORMARITIDINE; AMARBELLISINE; AMARYLLIDACEAE ALKALOID; AMBELLINE; ANTINEOPLASTIC AGENT; BUPHANAMINE; BUPHANISINE; C10B HYDROXYPANCRATISTATIN; CLIVIMINE; COLLAGEN TYPE 1; CRININE; DIHYDRONARCICLASINE; HAEMANTHAMINE; HIPPEASTRINE; LYCORENINE; LYCORIN 2 ONE; LYCORINE; LYCORINE 1,2 DIACETATE; N METHYLLYCORINE IODIDE; NARCICLASINE; NARCICLASINE TETRAACETATE; NOBILISTINE A; NOBILISTINE B; PSEUDOLYCORIN; TAZETTINE; UNCLASSIFIED DRUG; UNGEREMINE; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOSIS INHIBITION; STRUCTURE ANALYSIS;

AMARYLLIDACEAE ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LEUKEMIA; LILIACEAE; MOLECULAR STRUCTURE; NEOPLASM INVASIVENESS; PHYTOTHERAPY; PLANT EXTRACTS;

AMARYLLIDACEAE;

EID: 67651157036     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185340     Document Type: Article

References (57)

1. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 2003; 66: 1022-1037
2. Hartwell JL. Plants used against cancer. A survey. Lloydia 1967; 30: 379
3. Gardeil JB (translator). Traduction des Oeuvres Médicales d'Hippocrate. Toulouse: Fages, Meilhec et Cie; 1801 (4 vols)
4. Martin SF. The alkaloids. New York: Academic Press; 1987: 251
5. Gibbs RD. Chemotaxonomy of flowering plants. Vol.III. Montreal: McGill-Queen's University Press; 1974: 1924
6. Tojo E. (+)-Narcidine, a new alkaloid from Nacissus pseudonarcissus. J Nat Prod 1991; 54: 1387-1388
7. Noumbissie BE, Kapnang H, Fomum ZT, Martin MT, Bodo B. The myristicaeae of Cameroon. 1. Staudtienic acid, a diterpene from Staudtia kamerunesis. J Nat Prod 1992; 55: 137-139
8. Bastida J, Codina C, Viladomat F, Rubiralta M, Quirion JC,Weniger B. Narcissus alkaloids. 14. (+)-8-O-acetylhomolycorine and vasconine, 2 novel alkaloids from Narcissus vasconicus. J Nat Prod 1992; 55: 122-125
9. Plinius Secundus C (Pliny the Elder). Natural history, translated by J. Bostock and H. T. Riley. London: Bohn; 1855 (6 vols)
10. Hartwell JL. Plants used against cancer. Lawrencee, Massachusetts: Quarterman Publication; 1982
11. Kosteletzky BF. Allgemeine medizinisch-pharmazeutische Flora. Prag: Borrosch and André; 1831-1836: 6 vols
12. Hoshino O. The Amarillidaceae alkaloids. In: Cordell GA, editor. The alkaloids. Vol.51. London: Academic Press; 1998: 323-376
13. Cook JW, Loudon JD. The alkaloids. New York: Academic Press; 1952: 331
14. Carrasco L, Fresno M, Vazquez D. Narciclasine: an antitumor alkaloid which blocks peptide bond formation by eukaryotic ribosomes. FEBS Lett 1975; 52: 236-239
15. Jimenez A, Sanchez L, Vazquez D. Location of resistance to the alkaloid narciclasine in the 60S ribosomal subunit. FEBS Lett 1975; 55: 53-56
16. Jimenez A, Santos A, Alonso G, Vasquez D. Inhibitors of protein synthesis in eukariotic cells. Comparative effects of some Amaryllidaceae alkaloids. Biochim Biophys Acta 1976; 425: 342-348
17. Kornienko A, Evidente A. Chemistry, biology, and medicinal potential of narciclasine and its congeners. Chem Rev 2008; 108: 1982-2014
18. Vial JP, Belloc F, Dumain P, Besnard S, Lacombe F, Boisseau MR, Reiffers J, Bernard P. Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells. Leuk Res 1997; 21: 163-172 (Pubitemid 27141868)
19. Zhang HZ, Kasibhatla S, Kuemmerle J, Kemnitzer W, Ollis-Mason K, Qiu L, Crogan-Grundy C, Tseng B, Drewe J, Cai SX. Discovery and structure-activity relationship of 3-aryl-5-aryl-1, 2, 4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents. J Med Chem 2005; 48: 5215-5223
20. Kemnitzer W, Kasibhatla S, Jiang S, Zhang H, Zhao J, Jia S, Xu L, Crogan-Grundy C, Denis R, Barriault N, Vaillancourt L, Charron S, Dodd J, Attardo G, Labrecque D, Lamothe S, Gourdeau H, Tseng B, Drewe J, Cai SX. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions. Bioorg Med Chem Lett 2005; 15: 4745-4751
21. Kemnitzer W, Drewe J, Jiang S, Zhang H, Wang Y, Zhao J, Jia S, Herich J, Labreque D, Storer R, Meerovitch K, Bouffard D, Rej R, Denis R, Blais C, Lamothe S, Attardo G, Gourdeau H, Tseng B, Kasibhatla S, Cai SX. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. JMed Chem 2004; 47: 6299-6310
22. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005; 438: 967-974
23. Dickinson RB, Johnson MD, Maemura M, Low J. Anti-invasion drugs. Breast Cancer Res Treat 1996; 38: 121-132
24. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 2006; 59: 15-26
25. Khasig PZ, Pdobed OV, Gracheva TS, Salbiev KD, Grachev SV, Brezov TT. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis. Biochem Moscow 2003; 68: 711-717
26. Evidente A, Iasiello I, Randazzo G. An improved method for the large-scale preparation of lycorine. Chem Ind 1984: 348-349 (Pubitemid 14645512)
27. 13C-NMR data and a new improved method of preparation. Planta Med 1991; 57: 293-295
28. Evidente A, Andolfi A, Abou-Donia AH, Touema SM, Hammoda HM, Shawsky E, Motta A. (-)-Amarbellisine, a lycorine-type alkaloid from Amaryllis belladona L. growing in Egypt. Phytochemistry 2004; 65: 2113-2118 (Pubitemid 38981664)
29. Evidente A, Abou-Donia AH, Darwish FA, AmerME, Kassem FF, Hammoda HAM. Nobilisitines A and B, two masanane-type alkaloids from Clivia nobilis. Pytochemistry 1999; 51: 1151-1155
30. Evidente A, Andolfi A, Abou-Donia AH, Darwish FA, Hammoda HAM, Motta A. Minor alkaloids from Clivia nobilis Regel. Alex J Pharm Sci 2005; 19: 49-53
31. Abou-Donia AH, Abib AA, El Din AS, Evidente A, Gaber M, Scopa A. Two betaine-type alkaloids from bulbs of Pancratium maritimum. Phytochemistry 1992; 31: 2139-2141
32. Evidente A, Cicala MR, Randazzo G, Riccio R, Calabrese G, Liso R, Arrigoni O. Lycorine structure-activity relationships. Phytochemistry 1983; 22: 2192-2196
33. Evidente A, Arrigoni O, Liso R, Calabrese G, Randazzo G. Further experiments on lycorine-structure-activity relationships among the lycorine alkaloids. Phytochemistry 1986; 25: 2739-2743
34. Mondon A, Krohn K. Chemistry of narciclasine. Chem Berlin 1975; 108: 445-463
35. Pettit GR, Melody N, O'Sullivan M, Thompson MA, Herald DL, Coates B. Synthesis of B-10-R-hydroxypancratistatin via narciclasine. J Chem Soc Chem Commun 1994: 2725-2726
36. Pettit GR, Melody N, Herald DL, Schmidt JM, Pettit RK, Chapuis JC. Synthesis of 10b(R)-hydroxypancratistatin, 10b(S)-hydroxy-1-epipancratistatin, 10b(S)-hydroxy-1, 2-diepipancratistatin and related isocarbostyrils. Heterocycles 2002; 56: 139-155
37. Mosmann T. Rapid colorimetric assay for cellular growth and survival - application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63 (Pubitemid 14203433)
38. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis - flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled annexin-V. J Immunol Methods 1995; 184: 39-51
39. Pettit GR, Pettit III GR, Backhaus RA, Boyd MR,Meerow AW. Antineoplastic agents, 256. Cell growth inhibitory isocarbostylis from Hymenocallis. J Nat Prod 1993; 56: 1682-1687
40. Dumont P, Ingrassia L, Rouzeau S, Ribaucour F, Thomas S, Roland I, Darro F, Lefranc F, Kiss R. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts. Neoplasia 2007; 9: 766-776 (Pubitemid 47523238)
41. Weniger B, Italiano L, Beck JP, Bastida J, Bergonon S, Codina C, Lobstein A, Anton R. Cytotoxic activity of Amaryllidaceae alkaloids. Planta Med 1995; 61: 77-79
42. Hohmann J, Forgo P, Molnar J, Wolfard K, Molnar A, Thalhammer T, Máthé I, Sharples D. Antiproliferative Amaryllidaceae alkaloids isolated from the bulbs of Sprekelia formosissima and Hymenocallis x festalis. Planta Med 2002; 68: 454-457 (Pubitemid 34606692)
43. Barthelmes HU, Niederberger E, Roth T, Schulte K, Tang WC, Boege F, Fiebig HH, Eisenbrand G, Marko D. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells. Br J Cancer 2001; 85: 1585-1591 (Pubitemid 34001594)
44. Liu J, Hu WX, He LF, Ye M, Li Y. Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis. FEBS Lett 2004; 578: 245-250 (Pubitemid 39601789)
45. Li Y, Liu J, Tang LJ, Shi YW, Ren W, Hu WX. Apoptosis induced by lycorine in KM3 cells is associated with the G0/G1 cell cycle arrest. Oncol Rep 2007; 17: 377-384
46. McNulty J, Nair JJ, Codina C, Bastida J, Pandey S, Gerasimoff J, Griffin C. Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids. Phytochemistry 2007; 68: 1068-1074 (Pubitemid 46413332)
47. Abou-Donia AH, Arner ME, Darwish FA, Kassem FF, Hammoda HAM, Abdel-Kader MS, Zhou BN, Kingston DGI. Two new alkaloids of the crinane series from Pancratium sickenbergeri. Planta Med 2002; 68: 379-381
48. Christofori G. New signals from the invasive front. Nature 2006; 25: 441-450
49. Mareel MM, Bracke ME, Van Roy FM, de Baetselier P. Molecular mechanisms in cancer invasion. Vol.II. In: Bertino JR, editor. Encyclopedia of cancer. San Diego: Academic Press; 1997: 1072-1083
50. Schor SL, Schor AM, Winn B, Rushton G. The use of 3-dimensional collagen gels for the study of tumor-cell invasion in vitro: experimental parameters influencing cell-migration into the gel matrix. Int J Cancer 1982; 29: 57-62 (Pubitemid 12205562)
51. Bracke ME, Boterberg T, Bruyneel EA, Mareel MM. Collagen invasion assay. In: Brooks S, Schumacher U, editors. Metastasis research protocols. Totowa: Humana Press; 2001: 81-89
52. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994; 162: 499-510 (Pubitemid 24144126)
53. Klein CE, Dressel D, Steinmayer T, Mauch C, Eckes B, Krieg T, Blanke L. Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol 1991; 115: 1427-1436 (Pubitemid 21909986)
54. Vleminckxstarf K, Vakaet L, Mareel M, Fiersstarf W, Van Roystarf F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-119 (Pubitemid 121001351)
55. Meyer MB, Bastholm L, Nielsen MH, Elling F, Rygaard J, Chen W, Obrink B, Bock E, Edvardsen K. Localisation of NCAM on MCAM-B-expressing cells with inhibited migration in collagen. APMIS 1995; 103: 197-208
56. Suwa T, Hinoda Y, Makiguchi Y, Takahashi T, Itoh F, Adachi M, Hareyama H, Imai K. Increased invasiveness of MUC1 cDNA-transfected human gastric cancer MKN74 cells. Int J Cancer 1998; 76: 377-382 (Pubitemid 28282937)
57. Sandager M, Nielsen ND, Stafford GI, van Staden J, Jäger KJ. Alkaloids from Boophane disticha with affinity to the serotonin transporter in rat brain. J Ethnopharmacol 2005; 98: 367-370 (Pubitemid 40461995)